A method for the treatment of diabetes mellitus type 2 comprising administering (c) desPro 36 Exendin-4(1-39)-Lys 6 -NH 2 or/and a pharmaceutically acceptable salt thereof, and (d) metformin or/and a pharmaceutically acceptable salt thereof, to a subject in need thereof.